Table 1.
Variation in the composition of microbial diversity at the genus level in numerous neurological disorders. Abundance or scarceness of specific genera in a particular neurological disease compared to in healthy controls, where ↑ represents higher in number compared to healthy ones, ↓ represents lower in number compared to healthy ones, and-represents not reported yet.
| GENUS | Alzheimer’s Disease | Parkinson’s Disease | Huntington’s Disease | Multiple Sclerosis |
|---|---|---|---|---|
| Bifidobacterium | ↓ | ↑ | ↑ | - |
| Clostridium | ↓ | ↓ | ↓ | ↑ |
| Dialister | ↓ | - | - | - |
| Turicibacter | ↓ | - | - | - |
| Bacteroides | ↑ | ↓ | ↓ | - |
| Blautia | ↑ | ↓ | - | ↑ |
| Bilophila | ↑ | - | - | - |
| Lactobacillus | - | ↓ | - | ↓ |
| Faecalibacterium | - | ↓ | ↑ | - |
| Coprococcus | - | ↓ | - | - |
| Prevotella | - | ↓ | ↑ | ↓ |
| Akkermansia | - | ↑ | - | ↑ |
| Methanobrevibacter | - | - | - | ↑ |
| Butyricimonas | - | - | - | ↓ |
| Collinsella | - | - | - | ↓ |
| Slackia | - | - | - | ↓ |
| Megamonas | - | - | ↓ | - |
| Gemmiger | - | - | ↑ | - |
| Allistipes | ↑ | - | ↓ | - |